$2.02B
$130 Million
0.0% of portfolio
3,728
Q1 2025
Added 0.05%
-
$79.2 Million
0.0% of portfolio
-
Q1 2025
Reduced 79.17%
$920M
$5.47 Million
0.0% of portfolio
617
Q1 2025
Reduced 45.73%
$1.79B
$3.14 Million
0.0% of portfolio
28
Q1 2025
Added 3.7%
$4.31B
$117 Million
0.0% of portfolio
21,332
Q1 2025
Reduced 6.7%
$1.09B
$630,000
0.0% of portfolio
40
Q3 2024
New
$1.25B
$184 Million
0.0% of portfolio
27,690
Q1 2025
Added 19,678.57%
$48.2B
$85.2 Million
0.0% of portfolio
3,883
Q1 2025
Reduced 79.21%
$311M
$5.17 Million
0.0% of portfolio
233
Q1 2025
Added 7.87%
$1.48B
$11.7 Million
0.0% of portfolio
302
Q1 2025
Reduced 45.88%
$0
$183,000
0.0% of portfolio
-
Q3 2024
New
$6.86B
$46.5 Million
0.0% of portfolio
90
Q1 2025
Reduced 43.04%
$319M
$229 Million
0.0% of portfolio
44,462
Q1 2025
Reduced 9.91%
$1.6B
$3.29 Million
0.0% of portfolio
98
Q1 2025
Added 8.89%
$5.76B
$2.83 Million
0.0% of portfolio
150
Q3 2024
New
$497M
$8.09 Million
0.0% of portfolio
543
Q1 2025
Reduced 47.18%
$371M
$1.04 Million
0.0% of portfolio
171
Q1 2025
Reduced 42.62%
$333M
$9.62 Million
0.0% of portfolio
498
Q1 2025
Reduced 45.27%
$356M
$1.11 Million
0.0% of portfolio
146
Q1 2025
Reduced 39.67%
-
$39.6 Million
0.0% of portfolio
-
Q1 2025
Reduced 45.24%
$1.28B
$1.42 Million
0.0% of portfolio
336
Q1 2025
Reduced 45.28%
$3.26B
$73.3 Million
0.0% of portfolio
1,825
Q1 2025
Reduced 45.23%
$506M
$8.24 Million
0.0% of portfolio
2,055
Q1 2025
Reduced 47.13%
$165M
$2.24 Million
0.0% of portfolio
266
Q1 2025
Reduced 46.59%
$76.3M
$401,000
0.0% of portfolio
99
Q1 2025
Reduced 47.06%
$3.73B
$171 Million
0.0% of portfolio
10,051
Q1 2025
Reduced 6.48%
$601M
$3.18 Million
0.0% of portfolio
8
Q1 2025
Reduced 42.86%
$761M
$270 Million
0.0% of portfolio
22,129
Q1 2025
Reduced 2.11%
$51.9B
$30.7 Million
0.0% of portfolio
2,008
Q1 2025
Reduced 93.89%
$6.33B
$307 Million
0.0% of portfolio
9,842
Q1 2025
Reduced 4.14%
$1.67B
$5.99 Million
0.0% of portfolio
341
Q4 2024
Added 902.94%
-
$661,000
0.0% of portfolio
-
Q4 2024
Reduced 99.9%
$500M
$1.17 Million
0.0% of portfolio
147
Q1 2025
Reduced 36.91%
$2.82B
$57.1 Million
0.0% of portfolio
511
Q1 2025
Reduced 79.12%
$405M
$2.61 Million
0.0% of portfolio
902
Q1 2025
Reduced 47.19%
$1.64B
$12.1 Million
0.0% of portfolio
801
Q1 2025
Reduced 46.28%
$32.4B
$297 Million
0.0% of portfolio
3,262
Q1 2025
Reduced 3.38%
$739M
$12.1 Million
0.0% of portfolio
764
Q1 2025
Reduced 96.11%
$1.97B
$13.4 Million
0.0% of portfolio
989
Q1 2025
Reduced 44.22%
$262M
$1.07 Million
0.0% of portfolio
292
Q1 2025
Reduced 43.63%
$3.59B
$165 Million
0.0% of portfolio
11,016
Q1 2025
Reduced 9.29%
$172M
$2.15 Million
0.0% of portfolio
589
Q1 2025
Reduced 56.75%
$210M
$2.09 Million
0.0% of portfolio
542
Q1 2025
Reduced 46.07%
$74.1M
$1.26 Million
0.0% of portfolio
866
Q1 2025
Reduced 52.42%
$468M
$1.29 Million
0.0% of portfolio
9
Q1 2025
Reduced 40.0%
Dianthus Therapeutics Inc
-
$6.97 Million
0.0% of portfolio
-
Q1 2025
Reduced 45.99%
-
$19.1 Million
0.0% of portfolio
-
Q1 2025
Reduced 46.24%
$1.27B
$17.4 Million
0.0% of portfolio
627
Q1 2025
Reduced 45.14%
$274M
$372,000
0.0% of portfolio
29
Q1 2025
Reduced 30.95%
$0
$33.7 Million
0.0% of portfolio
1,727
Q1 2025
Reduced 28.28%